Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.300
+0.010 (0.44%)
Oct 29, 2025, 10:26 AM EDT - Market open

Acumen Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
139103222221274-
Upgrade
Market Cap Growth
-1.32%-53.53%0.62%-19.22%--
Upgrade
Enterprise Value
3-126-602144-
Upgrade
Last Close Price
2.291.723.845.406.76-
Upgrade
PB Ratio
1.180.570.831.171.22-
Upgrade
P/TBV Ratio
1.180.570.831.171.22-
Upgrade
Debt / Equity Ratio
0.260.160.120.00--
Upgrade
Asset Turnover
-----0.06
Upgrade
Inventory Turnover
-729.95284.97229.51141.44114.24
Upgrade
Quick Ratio
5.796.2418.8122.7537.766.89
Upgrade
Current Ratio
5.976.4619.0123.0838.606.98
Upgrade
Return on Equity (ROE)
-75.71%-45.60%-22.98%-20.71%-76.44%-33.26%
Upgrade
Return on Assets (ROA)
-39.06%-25.96%-15.08%-13.25%-8.91%-19.11%
Upgrade
Return on Capital (ROIC)
-42.77%-27.97%-15.70%-13.66%-9.30%-22.46%
Upgrade
Earnings Yield
-98.52%-99.02%-23.55%-19.39%-36.77%-
Upgrade
FCF Yield
-84.96%-83.45%-19.38%-15.98%-6.58%-
Upgrade
Buyback Yield / Dilution
-3.87%-23.46%-19.72%-102.43%-4685.59%2.73%
Upgrade
Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q